Back to results
US 2020/0390702 A1Published application
Liposomal taxanes for treatment of sclc
AssigneePlus Therapeutics, Inc.
InventorMark T. Marino
Life of this patent
Estimating the term…
Abstract
Methods for therapy for a small cell lung cancer (SCLC), which may or may not respond to a first-line therapy or that progresses following cessation of a first-line chemotherapy is provided. Some methods include the administration of composition that comprises a protein-stabilized form of docetaxel, optionally in conjunction with a regimen of supportive care.
Claims20
A method of inhibiting, a small cell lung cancer in a subject, comprising:
- identifying a subject with small cell lung cancer;
- and
- administering to the subject a therapeutically effective amount of a protein-stabilized liposome that comprises docetaxel..
2-41. (canceled)
Dependencies are inferred from the claim text.